Longitudinal Plasma Lipidomics Reveals Distinct Signatures Following Surgery in Patients with Glioblastoma
Plasma lipidomics shows promise as a potential liquid biopsy approach for monitoring glioblastoma treatment but future studies will need to examine these findings in larger and well-controlled cohorts.
Authors
- Han Sung Lee
- Lina A. Dahabiyeh (ORCID: https://orcid.org/0000-0002-4688-7052)
- Orwa Aboud (ORCID: https://orcid.org/0000-0002-7916-1629)
- Rawad Hodeify (ORCID: https://orcid.org/0000-0002-1016-2287)
- Orin Bloch (ORCID: https://orcid.org/0000-0001-9810-6011)
- John Paul Aboubechara (ORCID: https://orcid.org/0000-0002-9363-5704)
- Jonathan Wesley Riess (ORCID: https://orcid.org/0000-0001-7370-7304)
- Oliver Fiehn (ORCID: https://orcid.org/0000-0002-6261-8928)
- Yin Liu (ORCID: https://orcid.org/0009-0004-4044-958X)
- Rubén Fragoso
Institutions
- University of Jordan (JO)
- American University of Ras Al Khaimah (AE)
- Neurological Surgery (US)
- University of California Davis Medical Center (US)
- University of California, Davis (US)
Publication Details
- Journal
- Metabolites
- Published
- 2025-10-15
- DOI
- https://doi.org/10.3390/metabo15100673
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67
Funders
- National Institutes of Health
- University of California, Davis
- National Cancer Institute